Veoneer Stock Price, News & Analysis (NYSE:VNE)

Veoneer trades on the New York Stock Exchange (NYSE) under the ticker symbol "VNE."

Veoneer Inc (NYSE:VNE) announced its quarterly earnings results on Friday, July, 26th. The company reported ($1.39) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($1.57) by $0.18. The company earned $489 million during the quarter, compared to the consensus estimate of $482.35 million. Veoneer had a negative return on equity of 23.18% and a negative net margin of 22.11%. View Veoneer's Earnings History.

Veoneer is scheduled to release their next quarterly earnings announcement on Wednesday, October 23rd 2019. View Earnings Estimates for Veoneer.

Veoneer will be holding an earnings conference call on Wednesday, October 23rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

13 analysts have issued 1 year price objectives for Veoneer's shares. Their predictions range from $18.00 to $43.00. On average, they expect Veoneer's stock price to reach $29.56 in the next year. This suggests a possible upside of 78.4% from the stock's current price. View Analyst Price Targets for Veoneer.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veoneer in the last year. There are currently 1 sell rating, 8 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Veoneer.

News stories about VNE stock have trended somewhat negative on Saturday, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Veoneer earned a daily sentiment score of -1.5 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Veoneer.

Veoneer saw a drop in short interest in September. As of September 30th, there was short interest totalling 8,610,000 shares, a drop of 10.5% from the August 30th total of 9,620,000 shares. Based on an average daily volume of 655,100 shares, the short-interest ratio is presently 13.1 days. Approximately 7.8% of the company's shares are sold short. View Veoneer's Current Options Chain.

Some companies that are related to Veoneer include Gentex (GNTX), Autoliv (ALV), Allison Transmission (ALSN), Dorman Products (DORM), LCI Industries (LCII), Adient (ADNT), Dana (DAN), Meritor (MTOR), Gentherm (THRM), Delphi Technologies (DLPH), Standard Motor Products (SMP), American Axle & Manufact. (AXL), Stoneridge (SRI), IOCHPE MAXION S/S (IOCJY) and Garrett Motion (GTX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Veoneer investors own include Canadian Zinc (CZN), Bayer (BAYN), Seeing Machines (SEE), Eyegate Pharmaceuticals (EYEG), Netflix (NFLX), NVIDIA (NVDA), PepsiCo (PEP), Autoliv (ALV), The Coca-Cola (KO) and Prudential Financial (PRU).

Veoneer's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include DNB Asset Management AS (0.75%), Gateway Investment Advisers LLC (0.10%) and Zurcher Kantonalbank Zurich Cantonalbank (0.01%). Company insiders that own Veoneer stock include Arthur Blanchford, Jan Carlson, Mathias Hermansson and Mikko S Taipale. View Institutional Ownership Trends for Veoneer.

VNE stock was sold by a variety of institutional investors in the last quarter, including DNB Asset Management AS and Gateway Investment Advisers LLC. View Insider Buying and Selling for Veoneer.

VNE stock was purchased by a variety of institutional investors in the last quarter, including Zurcher Kantonalbank Zurich Cantonalbank . Company insiders that have bought Veoneer stock in the last two years include Arthur Blanchford, Jan Carlson, Mathias Hermansson and Mikko S Taipale. View Insider Buying and Selling for Veoneer.

Shares of VNE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of VNE stock can currently be purchased for approximately $16.57.

Veoneer has a market capitalization of $1.85 billion and generates $2.23 billion in revenue each year. The company earns $-275,000,000.00 in net income (profit) each year or ($3.17) on an earnings per share basis. Veoneer employs 8,600 workers across the globe.View Additional Information About Veoneer.

The official website for Veoneer is http://www.veoneer.com/.

Veoneer's mailing address is KLARABERGSVIADUKTEN 70 SECTION C6 BOX 13089, STOCKHOLM V7, 10302. The company can be reached via phone at 46-8-527-762-00 or via email at [email protected]